Yahoo
NSE - Delayed Quote INR

Balaji Amines Limited (BALAMINES.NS)

1,765.80 -83.00 (-4.49%)
At close: October 30 at 3:29:58 PM GMT+5:30
Chart Range Bar
Loading chart for BALAMINES.NS
  • Previous Close 1,848.80
  • Open 1,864.00
  • Bid --
  • Ask --
  • Day's Range 1,755.00 - 1,864.00
  • 52 Week Range 968.10 - 2,629.80
  • Volume 140,969
  • Avg. Volume 236,989
  • Market Cap (intraday) 57.214B
  • Beta (5Y Monthly) 0.91
  • PE Ratio (TTM) 27.90
  • EPS (TTM) 63.28
  • Earnings Date (est.) --
  • Forward Dividend & Yield 11.00 (0.62%)
  • Ex-Dividend Date Jul 3, 2026
  • 1y Target Est 2,123.00

Balaji Amines Limited engages in the manufacture and sale of methylamines, ethylamines, and derivatives of specialty chemicals and pharma excipients in India and internationally. The company operates in two segments, Chemicals and Hotel. It offers monomethylamine, dimethylamine, trimethylamine, monoethylamine, diethylamine, triethylamine, and dimethyl and diethyl amino ethanol; and specialty chemicals, including N-methyl pyrrolidone, morpholine, 2-pyrrolidone, N-ethyl-2-pyrrolidone, gamma-butyrolactone, dimethylformamide, acetonitrile, dimethylcarbonate, propylene glycol, and propylene carbonate. The company also provides derivatives comprising di-methyl acetamide, di-methyl amine hydrochloride, tri-methyl amine hydrochloride, di-ethyl amine hydrochloride, tri-ethyl amine hydrochloride, di-methyl urea, choline chloride, mono-ethyl amine hydrochloride, and benzyl tri ethyl ammonium chloride; and pharma excipients, such as poly vinyl pyrrolidone. It also provides hotels, restaurants, and hospitality services. The company also exports its products to Europe, the United States, and Japan. Balaji Amines Limited was incorporated in 1988 and is headquartered in Hyderabad, India.

www.balajiamines.com

1,161

Full Time Employees

March 31

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

BALAMINES.NS
58.30%
S&P BSE SENSEX (^BSESN)
12.63%

1-Year Return

BALAMINES.NS
25.66%
S&P BSE SENSEX (^BSESN)
11.78%

3-Year Return

BALAMINES.NS
12.01%
S&P BSE SENSEX (^BSESN)
16.14%

5-Year Return

BALAMINES.NS
47.82%
S&P BSE SENSEX (^BSESN)
25.55%

Earnings Trends

View More

Earnings Per Share (Normalized)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY27
Revenue 4.56B
Earnings --
Profit Margin 0.00%

Q2

FY26

Q3

FY26

Q4

FY26

Q1

FY27

0
1B
2B
3B
4B
0.0%
2.0%
4.0%
6.0%
8.0%

Analyst Insights

View More

Analyst Price Targets

1,334.00 Low
2,123.00 Average
1,765.80 Current
3,327.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    13.41%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    15.23B

  • Net Income Avi to Common (ttm)

    2.04B

  • Diluted EPS (ttm)

    63.28

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.7B

  • Total Debt/Equity (mrq)

    6.19%

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: